生命科学资讯

Insmed’s ‘win streak’ ends as top drug fails study in chronic nasal condition

Takeda says $4B TYK2 drug succeeds in large psoriasis studies

Orum, a biotech marrying ADCs with protein degraders, captures $100M in funding

FDA clears GSK’s twice-yearly asthma drug

Peanut allergy patch succeeds in late-stage study 5 years after FDA rejection

RA Capital backs drug for rare kind of chronic pain

Addition emerges with $100M to make gene therapies for chronic and rare diseases

Developing a path forward in cancer cachexia

Nektar sees silver lining as autoimmune drug ‘narrowly’ misses in alopecia study

FDA ‘proactively’ hands J&J a voucher; Pfizer issues 2026 forecasts

Enhertu combo cleared for use in frontline breast cancer

‘Zombie’ biotech buyer Xoma to acquire Generation Bio

Argenx falters in effort to expand immune drug’s use

Sanofi MS drug hits two setbacks

Kyverna to seek first clearance of a CAR-T therapy for autoimmune disease

How rare-disease teams can fine-tune COAs to bridge meaningful change and measurable progress

Sobi snaps up gout drug in $950M deal for startup Arthrosi

Arcus cancels work on Gilead-partnered cancer combo after trial setback

Praxis tees up another approval filing; Geron turns to layoffs

AC Immune posts positive data for Parkinson’s immunotherapy